DRTSW Alpha Tau Medical Ltd.
Fundamentals / CIK 0001871321 / USDAlpha Tau Medical Ltd. reported $105.7M in total assets and a net loss of $42.63M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DRTSW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$42.29M Operating profit
-
Net Income FY 2025-$42.63M GAAP bottom line
-
Diluted EPS FY 2025-$0.53 Split-adjusted
-
Free Cash Flow FY 2025-$32.76M Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2025$73.13M Total debt: $7.37M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Research & Development | $32.06M | $27.02M | $26.42M | $20.89M | $11.45M | $7.54M | $6.64M |
| Operating Income | -$42.29M | -$36.04M | -$35.68M | -$32.14M | -$13.79M | -$9.24M | $8.01M |
| EBITDA | -$41.06M | -$34.94M | -$34.61M | -$31.16M | -$13.01M | -$9.16M | $8.08M |
| Interest Expense | $347K | $303K | $75K | -- | -- | -- | -- |
| Income Before Tax | -$42.51M | -$31.74M | -$29.14M | -$33.74M | -$27.26M | -$8.72M | $8.32M |
| Income Tax Expense | $121K | $6.0K | $16K | $20K | $7.0K | $158K | -$146K |
| Net Income | -$42.63M | -$31.75M | -$29.16M | -$33.76M | -$27.27M | -$8.88M | -$8.37M |
| Basic EPS | -$0.53 | -$0.45 | -$0.42 | -$0.53 | -$0.67 | -$0.22 | -$0.25 |
| Diluted EPS | -$0.53 | -$0.45 | -$0.42 | -$0.53 | -$0.67 | -$0.22 | -$0.25 |
| Basic Shares Outstanding | 80.6M | 69.9M | 69.4M | 63.5M | 40.5M | 40.3M | 33.8M |
| Diluted Shares Outstanding | 80.6M | 69.9M | 69.4M | 63.5M | 40.5M | 40.3M | 33.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $12.20M | $13.72M | $12.66M | $5.84M | $23.24M | $15.60M |
| Short-Term Investments | $60.92M | $45.88M | $69.13M | $98.69M | $8.08M | -- |
| Cash & Short-Term Investments | $76.90M | $62.85M | $84.94M | $104.5M | $31.32M | $15.60M |
| Total Current Assets | $78.30M | $64.23M | $85.76M | $106.5M | $32.64M | $47.45M |
| Property, Plant & Equipment, Net | $19.66M | $13.93M | $12.80M | $7.47M | $7.55M | $5.39M |
| Total Non-Current Assets | $27.35M | $21.98M | $21.63M | $13.67M | $9.57M | $5.53M |
| Total Assets | $105.7M | $86.20M | $107.4M | $120.1M | $42.22M | $52.99M |
| Accounts Payable | $3.87M | $3.53M | $2.57M | $1.42M | $1.20M | $964K |
| Other Current Liabilities | -- | -- | -- | -- | $3.20M | $1.12M |
| Total Current Liabilities | $10.51M | $8.68M | $7.10M | $4.34M | $4.41M | $2.09M |
| Total Non-Current Liabilities | $18.05M | $14.86M | $15.81M | $10.15M | $18.62M | $5.37M |
| Total Liabilities | $28.55M | $23.54M | $22.91M | $14.49M | $23.03M | $7.45M |
| Total Debt (incl. Leases) | $7.37M | $6.97M | $7.67M | $5.19M | -- | -- |
| Retained Earnings | -$190.1M | -$147.5M | -$115.8M | -$86.60M | -$52.84M | -$25.57M |
| Total Stockholders' Equity | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |
| Total Equity | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $12.20M | $13.72M | $12.66M | $5.84M | $23.24M | $15.60M |
| Short-Term Investments | $60.92M | $45.88M | $69.13M | $98.69M | $8.08M | -- |
| Cash & Short-Term Investments | $76.90M | $62.85M | $84.94M | $104.5M | $31.32M | $15.60M |
| Total Current Assets | $78.30M | $64.23M | $85.76M | $106.5M | $32.64M | $47.45M |
| Property, Plant & Equipment, Net | $19.66M | $13.93M | $12.80M | $7.47M | $7.55M | $5.39M |
| Total Non-Current Assets | $27.35M | $21.98M | $21.63M | $13.67M | $9.57M | $5.53M |
| Total Assets | $105.7M | $86.20M | $107.4M | $120.1M | $42.22M | $52.99M |
| Accounts Payable | $3.87M | $3.53M | $2.57M | $1.42M | $1.20M | $964K |
| Other Current Liabilities | -- | -- | -- | -- | $3.20M | $1.12M |
| Total Current Liabilities | $10.51M | $8.68M | $7.10M | $4.34M | $4.41M | $2.09M |
| Total Non-Current Liabilities | $18.05M | $14.86M | $15.81M | $10.15M | $18.62M | $5.37M |
| Total Liabilities | $28.55M | $23.54M | $22.91M | $14.49M | $23.03M | $7.45M |
| Total Debt (incl. Leases) | $7.37M | $6.97M | $7.67M | $5.19M | -- | -- |
| Retained Earnings | -$190.1M | -$147.5M | -$115.8M | -$86.60M | -$52.84M | -$25.57M |
| Total Stockholders' Equity | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |
| Total Equity | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$42.63M | -$31.75M | -$29.16M | -$33.76M | $27.27M | $8.88M | $8.46M |
| Depreciation & Amortization | $1.23M | $1.10M | $1.07M | $979K | $776K | $86K | $66K |
| Stock-Based Compensation | $10.62M | $9.92M | $7.93M | $6.75M | $812K | $596K | $546K |
| Change in Payables | $337K | $965K | $1.14M | $220K | $239K | $114K | $148K |
| Operating Cash Flow | -$26.68M | -$19.78M | -$17.96M | -$23.88M | -$11.81M | -$7.25M | -$6.91M |
| Capital Expenditure | -$6.08M | -$2.24M | -$6.40M | -$904K | -$2.93M | -$3.77M | -$1.29M |
| Free Cash Flow | -$32.76M | -$22.02M | -$24.36M | -$24.78M | -$14.74M | -$11.02M | -$8.20M |
| Investing Cash Flow | -$20.59M | $20.77M | $18.68M | -$89.94M | $19.27M | -$7.82M | -$10.16M |
| Common Stock Issued | $45.50M | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | $45.77M | $25K | $5.30M | $96.91M | $111K | $29.32M | $5.32M |
| Net Change in Cash | -$1.52M | $1.07M | $5.97M | -$17.17M | $7.68M | $14.33M | -$11.77M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -55.3% | -50.7% | -34.5% | -32.0% | -- | -- | -- |
| Return on Assets (ROA) | -40.3% | -36.8% | -27.2% | -28.1% | -64.6% | -16.8% | -- |
| Current Ratio | 7.45x | 7.40x | 12.07x | 24.55x | 7.41x | 22.73x | -- |
| Quick Ratio | 7.32x | 7.25x | 11.96x | 24.10x | 7.11x | 7.47x | -- |
| Debt to Equity | 0.10x | 0.11x | 0.09x | 0.05x | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -215.4% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.